Published in Vaccine Weekly, January 31st, 2001
Anna L. Marsland, PhD, RN, of the Behavioral Medicine Program at the Western Psychiatric Institute and Clinic at the University of Pittsburgh School of Medicine, in Pennsylvania, and colleagues tested how 84 study participants responded to a vaccine against hepatitis B virus. This vaccination prompts the immune system to mount a defense by introducing a tiny amount of the infectious agent into the body.
The study participants were also given a test to measure...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly